Finally! Humira’s biosimilars also hit the us market!

Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :

Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :